Download PDF
Neuropediatrics 2010; 41(4): 157-162
DOI: 10.1055/s-0030-1267155
Review Article

© Georg Thieme Verlag KG Stuttgart · New York

A Practical Guide to Pediatric Multiple Sclerosis

P. Huppke1 , J. Gärtner1
  • 1Department of Pediatrics and Pediatric Neurology, Georg August University, Göttingen, Germany
Further Information

Publication History

received 01.03.2010

accepted 06.09.2010

Publication Date:
17 November 2010 (online)

Also available at
    Permissions and Reprints

Abstract

During the past 10 years much knowledge has been gained about multiple sclerosis in the pediatric population. This article summarizes the information relevant to the neurologist and pediatric neurologist concerning the diagnosis, differential diagnosis and therapy for pediatric MS.

Key words

multiple sclerosis - pediatrics - review

References

  • 1 Banwell B, Ghezzi A, Bar-Or A. et al . Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions.  Lancet neurology. 2007;  6 887-902
    CrossrefPubMedGoogle Scholar
  • 2 Banwell B, Kennedy J, Sadovnick D. et al . Incidence of acquired demyelination of the CNS in Canadian children.  Neurology. 2009;  72 232-239
    CrossrefPubMedGoogle Scholar
  • 3 Banwell B, Krupp L, Kennedy J. et al . Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.  Lancet neurology. 2007;  6 773-781
    CrossrefPubMedGoogle Scholar
  • 4 Banwell B, Reder AT, Krupp L. et al . Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.  Neurology. 2006;  66 472-476
    CrossrefPubMedGoogle Scholar
  • 5 Banwell B, Shroff M, Ness JM. et al . MRI features of pediatric multiple sclerosis.  Neurology. 2007;  68 S46-53
    CrossrefPubMedGoogle Scholar
  • 6 Banwell B, Tenembaum S, Lennon VA. et al . Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.  Neurology. 2008;  70 344-352
    CrossrefPubMedGoogle Scholar
  • 7 Boiko A, Vorobeychik G, Paty D. et al . Early onset multiple sclerosis: a longitudinal study.  Neurology. 2002;  59 1006-1010
    CrossrefPubMedGoogle Scholar
  • 8 Bonhomme GR, Waldman AT, Balcer LJ. et al . Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.  Neurology. 2009;  72 881-885
    CrossrefPubMedGoogle Scholar
  • 9 Borriello G, Prosperini L, Luchetti A. et al . Natalizumab treatment in pediatric multiple sclerosis: A case report.  Eur J Paediatr Neurol. 2008; 
    PubMedGoogle Scholar
  • 10 Chabas D, Castillo-Trivino T, Mowry EM. et al . Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?.  Neurology. 2008;  71 1090-1093
    CrossrefPubMedGoogle Scholar
  • 11 Chitnis T, Glanz B, Jaffin S. et al . Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.  Multiple sclerosis (Houndmills, Basingstoke, England). 2009;  15 627-631
    CrossrefPubMedGoogle Scholar
  • 12 Cohen BA, Khan O, Jeffery DR. et al . Identifying and treating patients with suboptimal responses.  Neurology. 2004;  63 S33-S40
    PubMedGoogle Scholar
  • 13 Ghezzi A. Immunomodulatory treatment of early onset multiple sclerosis: results of an Italian Co-operative Study.  Neurol Sci. 2005;  26 (S 04) S183-S186
    CrossrefPubMedGoogle Scholar
  • 14 Ghezzi A, Amato MP, Capobianco M. et al . Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study.  Multiple sclerosis (Houndmills, Basingstoke, England). 2005;  11 420-424
    CrossrefPubMedGoogle Scholar
  • 15 Ghezzi A, Banwell B, Boyko A. et al . The management of multiple sclerosis in children: a European view.  Multiple sclerosis (Houndmills, Basingstoke, England). 2010; 
    PubMedGoogle Scholar
  • 16 Ghezzi A, Deplano V, Faroni J. et al . Multiple sclerosis in childhood: clinical features of 149 cases.  Multiple sclerosis (Houndmills, Basingstoke, England). 1997;  3 43-46
    CrossrefPubMedGoogle Scholar
  • 17 Hahn JS, Pohl D, Rensel M. et al . Differential diagnosis and evaluation in pediatric multiple sclerosis.  Neurology. 2007;  68 S13-S22
    PubMedGoogle Scholar
  • 18 Huppke P, Stark W, Zurcher C. et al . Natalizumab use in pediatric multiple sclerosis.  Archives of neurology. 2008;  65 1655-1658
    CrossrefPubMedGoogle Scholar
  • 19 Kornek B, Bernert G, Balassy C. et al . Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis.  Neuropediatrics. 2003;  34 120-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Kriss A, Francis DA, Cuendet F. et al . Recovery after optic neuritis in childhood.  Journal of neurology, neurosurgery, and psychiatry. 1988;  51 1253-1258
    CrossrefPubMedGoogle Scholar
  • 21 Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders.  Neurology. 2007;  68 S7-S12
    CrossrefPubMedGoogle Scholar
  • 22 Krupp LB, Macallister WS. Treatment of Pediatric Multiple Sclerosis.  Current treatment options in neurology. 2005;  7 191-199
    CrossrefPubMedGoogle Scholar
  • 23 Kuker W. Cerebral vasculitis: imaging signs revisited.  Neuroradiology. 2007;  49 471-479
    CrossrefPubMedGoogle Scholar
  • 24 Lucchinetti CF, Kiers L, O’Duffy A. et al . Risk factors for developing multiple sclerosis after childhood optic neuritis.  Neurology. 1997;  49 1413-1418
    CrossrefPubMedGoogle Scholar
  • 25 Makhani N, Gorman MP, Branson HM. et al . Cyclophosphamide therapy in pediatric multiple sclerosis.  Neurology. 2009;  72 2076-2082
    CrossrefPubMedGoogle Scholar
  • 26 McAdam LC, Blaser SI, Banwell BL. Pediatric tumefactive demyelination: case series and review of the literature.  Pediatric neurology. 2002;  26 18-25
    CrossrefPubMedGoogle Scholar
  • 27 McDonald WI, Compston A, Edan G. et al . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.  Annals of neurology. 2001;  50 121-127
    CrossrefPubMedGoogle Scholar
  • 28 McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index.  A comparison and diagnostic applications. Brain. 1990;  113 (Pt 5) 1269-1289
    PubMedGoogle Scholar
  • 29 Mikaeloff Y, Adamsbaum C, Husson B. et al . MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood.  Brain. 2004;  127 1942-1947
    CrossrefPubMedGoogle Scholar
  • 30 Mikaeloff Y, Suissa S, Vallee L. et al . First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability.  The Journal of pediatrics. 2004;  144 246-252
    CrossrefPubMedGoogle Scholar
  • 31 Neuteboom RF, Boon M, Catsman Berrevoets CE. et al . Prognostic factors after a first attack of inflammatory CNS demyelination in children.  Neurology. 2008;  71 967-973
    CrossrefPubMedGoogle Scholar
  • 32 Pittock SJ, Lennon VA, Krecke K. et al . Brain abnormalities in neuromyelitis optica.  Archives of neurology. 2006;  63 390-396
    CrossrefPubMedGoogle Scholar
  • 33 Pohl D, Rostasy K, Gartner J. et al . Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a.  Neurology. 2005;  64 888-890
    CrossrefPubMedGoogle Scholar
  • 34 Pohl D, Rostasy K, Reiber H. et al . CSF characteristics in early-onset multiple sclerosis.  Neurology. 2004;  63 1966-1967
    CrossrefPubMedGoogle Scholar
  • 35 Pohl D, Rostasy K, Treiber-Held S. et al . Pediatric multiple sclerosis: detection of clinically silent lesions by multimodal evoked potentials.  The Journal of pediatrics. 2006;  149 125-127
    CrossrefPubMedGoogle Scholar
  • 36 Pohl D, Waubant E, Banwell B. et al . Treatment of pediatric multiple sclerosis and variants.  Neurology. 2007;  68 S54-S65
    CrossrefPubMedGoogle Scholar
  • 37 Polman CH, Reingold SC, Edan G. et al . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.  Annals of neurology. 2005;  58 840-846
    CrossrefPubMedGoogle Scholar
  • 38 Renoux C, Vukusic S, Mikaeloff Y. et al . Natural history of multiple sclerosis with childhood onset.  The New England journal of medicine. 2007;  356 2603-2613
    CrossrefPubMedGoogle Scholar
  • 39 Riikonen R, Donner M, Erkkila H. Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children.  Developmental medicine and child neurology. 1988;  30 349-359
    CrossrefPubMedGoogle Scholar
  • 40 Sellner J, Luthi N, Buhler R. et al . Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis.  Eur J Neurol. 2008;  15 398-405
    CrossrefPubMedGoogle Scholar
  • 41 Stark W, Huppke P, Gartner J. Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence.  Journal of neurology. 2008;  255 (S 06) 119-122
    CrossrefPubMedGoogle Scholar
  • 42 Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients.  Neurology. 2002;  59 1224-1231
    CrossrefPubMedGoogle Scholar
  • 43 Tenembaum S, Chitnis T, Ness J. et al . Acute disseminated encephalomyelitis.  Neurology. 2007;  68 S23-S36
    CrossrefPubMedGoogle Scholar
  • 44 Tenembaum SN, Segura MJ. Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis.  Neurology. 2006;  67 511-513
    CrossrefPubMedGoogle Scholar
  • 45 Waubant E, Chabas D. Pediatric multiple sclerosis.  Current treatment options in neurology. 2009;  11 203-210
    CrossrefPubMedGoogle Scholar
  • 46 Waubant E, Chabas D, Okuda DT. et al . Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs. adults.  Archives of neurology. 2009;  66 967-971
    CrossrefPubMedGoogle Scholar
  • 47 Waubant E, Hietpas J, Stewart T. et al . Interferon beta-1a in children with multiple sclerosis is well tolerated.  Neuropediatrics. 2001;  32 211-213
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Wingerchuk DM, Hogancamp WF, O’Brien PC. et al . The clinical course of neuromyelitis optica (Devic's syndrome).  Neurology. 1999;  53 1107-1114
    CrossrefPubMedGoogle Scholar
  • 49 Yeh EA, Chitnis T, Krupp L. et al . Pediatric multiple sclerosis.  Nat Rev Neurol. 2009;  5 621-631
    CrossrefPubMedGoogle Scholar

Correspondence

Peter HuppkeMD 

Department of Pediatrics and

Pediatric Neurology

Georg August University

Faculty of Medicine

Robert-Koch-Straße 40

37075 Göttingen

Germany

Phone: +49/551/396 210

Fax: +49/551/396 252

Email: phuppke@med.uni-goettingen.de